Saccharopine Dehydrogenase (NADP+, L-lysine-forming)

Saccharopine Dehydrogenase (NADP+, L-lysine-forming) is an enzyme that plays a crucial role in the lysine degradation pathway, specifically in the amino acid metabolism. This enzyme catalyzes the sixth step of the lysine degradation pathway, which is a critical process for the catabolism of lysine, an essential amino acid in humans. The reaction facilitated by saccharopine dehydrogenase involves the conversion of saccharopine into lysine and alpha-aminoadipate semialdehyde, utilizing NADP+ as a cofactor. This process is vital for maintaining the balance of amino acids within the body and for the production of energy through the metabolism of lysine.

Function

Saccharopine dehydrogenase is encoded by the gene LOR in humans. The enzyme's primary function is to catalyze the cleavage of saccharopine, yielding L-lysine and alpha-aminoadipate semialdehyde. This reaction is reversible and plays a significant role in the lysine degradation pathway, which is part of the broader amino acid degradation processes. The enzyme's activity is crucial for the proper metabolism of lysine, an essential amino acid that must be obtained through the diet as the human body cannot synthesize it.

Structure

The enzyme saccharopine dehydrogenase is a protein that consists of multiple subunits, each with a specific role in the enzyme's catalytic activity. The structure of saccharopine dehydrogenase includes binding sites for its substrates, saccharopine, and NADP+, as well as for its products, L-lysine and alpha-aminoadipate semialdehyde. The precise structure of saccharopine dehydrogenase can vary among different species, but all share the common function of facilitating the lysine degradation pathway.

Clinical Significance

Mutations in the LOR gene, which encodes saccharopine dehydrogenase, can lead to a rare metabolic disorder known as hyperlysinemia type II. This condition is characterized by elevated levels of lysine in the blood, which can result in various symptoms, including developmental delay, seizures, and cognitive impairment. Diagnosis of hyperlysinemia type II involves biochemical testing to measure the levels of lysine and saccharopine in the blood and urine. Treatment typically focuses on dietary management to restrict lysine intake and may include supplementation with other amino acids to promote balance.

Research Directions

Research into saccharopine dehydrogenase and its role in lysine metabolism continues to uncover new insights into amino acid metabolism and its implications for human health. Studies are exploring the potential for targeted therapies to address metabolic disorders related to lysine metabolism, such as hyperlysinemia type II. Additionally, understanding the structure and function of saccharopine dehydrogenase at a molecular level may provide avenues for the development of novel treatments for metabolic disorders.

• Need help finding a doctor or specialist anywhere in the world? WikiMD's DocFinder can help with millions of doctors!

This article is a stub. Help WikiMD grow by registering to expand it. Editing is available only to registered and verified users. About WikiMD: A comprehensive, free health & wellness encyclopedia.